You searched for "outcomes"

1558 results found

Outcomes in intermediate age-related macular degeneration (AMD): A MACUSTAR study report

Intermediate AMD (iAMD) is the most high-risk AMD stage for progressing to late AMD. This article gives the report of the MACUSTAR study. A wide range of assessments were conducted across 20 sites in seven European countries, in accordance with...

Long-term outcomes after acute primary angle closure

This is a retrospective observational study including 121 eyes of 117 consecutive patients with acute primary angle closure (APAC) over a four-year period, between 1 January 2010 to 31 December 2014. Seventy-three percent had achieved visual acuities of ≥ 6/12,...

Orbital cellulitis in Scotland: current incidents, aetiology, management and outcomes

This is a one year prospective study using the Scottish ophthalmic surveillance unit reporting system amongst Scottish ophthalmologists. Only patients residing within Scotland with a new diagnosis of orbital cellulitis between November 2011 and October 2012 were including in this...

Periocular burns: a literature review of classification, management protocols and outcomes of treatment

The author provides a review of the current literature regarding the principles of classification, management protocols of acute ocular and periocular burns and the role of the burn and oculoplastic surgeon involved in their care. More than two-thirds of facial...

Comparison of outcomes of bilateral cataract surgery across different age groups

The authors present a retrospective records review of children who had bilateral cataract surgery between the ages of two and seven years of age over a 23-year period. Children with other ocular pathology and prior surgery were excluded. A minimum...

Outcomes of combined medial and laser treatment for advanced Coat’s disease

In this study, the anatomical and visual outcomes of paediatric patients with advanced stage 3+ Coat’s disease are reported. Patients were treated with a combination of intravitreal ranibizumab, laser photocoagulation and methyl prednisolone acetate. This was a retrospective review of...

Outcomes of suture-less vs. sutured wound closure for paediatric cataract surgery

In this study the authors aimed to compare the incidence of postoperative complications between cases of suture-less and sutured wound closure in paediatric cataract surgery. This was a retrospective study of children aged <18 years and included 116 eyes of...

Long-term outcomes of deep anterior lamellar versus penetrating keratoplasty for keratoconus

This is a retrospective consecutive and comparative case series of keratoplasties (228 deep anterior lamellar keratoplasties (DALKs) and 274 penetrating keratoplasties (PKs)) in a single centre by one surgeon in France, between 1993 and 2021. Graft survival was 96.7% at...

Differences in strabismus surgery outcomes in preterm vs full-time birth infants

This study aimed to analyse motor and sensory outcomes of strabismus surgery in 70 preterm (group 1) and 242 full-term (group 2) infants. Group 1 mean gestational age and birth weight were 31.25 ±2.51 weeks and 1562.70 ±412.82g. Pre and...

Leber’s hereditary optic neuropathy outcomes in an Indian population

A large cohort study in an Indian population is presented, with clinical and genetic profile analysis of patients with Leber’s hereditary optic neuropathy (LHON) treated over a five-year period. The study included 157 patients; 143 male, 14 female (10.2:1 ratio)...

Better outcomes from early repair of Type B blow-out fractures

This paper examines whether early, rather than late, surgical repair results in better motility outcomes for a particular subgroup of orbital floor blowout fractures. The authors divide floor fractures into Types A and B, depending on whether or not the...

Anatomical and functional outcomes following switching from aflibercept to ranibizumab in NARMD

This is a six-month, prospective, single-arm study in the UK and Germany. A total of 100 patients were enrolled (one in the primary failure group, 99 in the suboptimal treatment response group), treated three-monthly intravitreal ranibizumab injections (0.5mg), and then...